DLH Reports Fiscal 2023 Third Quarter Results

August 2, 2023

Quarterly Revenue Over $100 Million; Active Pipeline of Opportunities to Accelerate Growth in Fiscal 2024

ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of research and development, systems engineering and integration, and digital transformation solutions to federal agencies, today announced financial results for its fiscal third quarter ended June 30, 2023.


  • Third quarter revenue was $102.2 million in fiscal 2023 versus $66.4 million in fiscal 2022; the prior-year period included an adjustment of $(5.1) million related to the short-term FEMA task orders in Alaska, without which revenue was $71.6 million.
  • Operating and net income for the third quarter were $7.1 million and $1.7 million, respectively, as compared to $7.1 million and $4.9 million in the prior-year period. Operating income for the fiscal 2022 quarter included $0.6 million from the FEMA task orders.
  • Earnings before interest, taxes, depreciation and amortization ("EBITDA") was $11.4 million for the third quarter as compared to $9.0 million in fiscal 2022. The prior-year period included $0.6 million of EBITDA from the FEMA task orders.
  • Total debt at the end of the third quarter was $195.8 million compared to $204.2 million as of March 31, 2023.
  • Contract backlog was $817.8 million as of June 30, 2023 versus $940.6 million at the end of the fiscal second quarter.

Management Discussion
"Third quarter performance once again highlighted the Company's ability to produce strong underlying results," said Zach Parker, DLH President and Chief Executive Officer. "We passed the $100 million revenue run rate, improved margins sequentially from the second quarter, used cash flow to continue paying down debt and successfully accomplished several milestones in the GRSi integration. The contract award environment continues to experience some headwinds, reflecting certain contract protests and extensive procurement cycles. The Company remains in excellent position to capitalize on current market dynamics and execute on new business development initiatives, resulting in an active bid environment. Our expanded health IT suite of solutions — leveraging unique applications and our highly-credentialed staff — provides us access to penetrate new programs within the key government agencies we serve. At the same time, with our ability to generate healthy cash from operations, we remain on track to de-lever the balance sheet in the coming quarters, which we expect will result in increased returns to our shareholders.

"In addition, we recently announced that DLH had been awarded a contract to expand our role at the National Heart, Lung and Blood Institute within the National Institutes of Health. The multiple-award contract has a total ceiling value of up to $85 million over five years, and we'll be responsible for driving key digital transformation goals for the agency. Overall, we continue to see numerous opportunities to accelerate growth going forward, leveraging our expanded set of technology solutions, and are well prepared for further improved performance."

Results for the Three Months Ended June 30, 2023
Revenue for the third quarter of fiscal 2023 was $102.2 million versus $66.4 million in fiscal 2022, with the prior-year period including an adjustment of $(5.1) million related to the Company's short-term FEMA contracts in Alaska. Comparing this quarter's revenue performance to the same period in the prior fiscal year, excluding the impact from the FEMA contracts, revenue increased $30.6 million, including contributions of $34.4 million from GRSi.

Income from operations was $7.1 million for the quarter versus $7.1 million in the prior-year period, which included $0.6 million from the FEMA task orders. Comparing this quarter's operating income performance to the same period in the prior fiscal year, excluding the impact from the FEMA contracts, operating income increased $0.6 million. As a percentage of revenue, the Company reported an operating margin of 7.0% in the fiscal 2023 third quarter versus 10.7% in fiscal 2022, with the year-over-year decline primarily due to higher non-cash amortization expense as a result of the GRSi acquisition.

Interest expense was $4.9 million in the fiscal third quarter of 2023 versus $0.5 million in the prior-year period, reflecting higher debt outstanding due to the acquisition of GRSi and increased interest rates. Income before income taxes was $2.2 million this year versus $6.6 million in fiscal 2022, representing 2.1% and 9.9% of revenue, respectively, for each period.

For the three months ended June 30, 2023 and 2022, respectively, DLH recorded a $0.5 million and $1.7 million of income tax expense. The Company reported net income of approximately $1.7 million, or $0.12 per diluted share, for the third quarter of fiscal 2023 versus $4.9 million or $0.34 per diluted share, for the third quarter of fiscal 2022. As a percentage of revenue, net income was 1.7% for the third quarter of fiscal 2023 versus 7.3% for the prior-year period.

On a non-GAAP basis, EBITDA for the three months ended June 30, 2023 was approximately $11.4 million versus $9.0 million in the prior-year period, or 11.1% and 13.5% of revenue, respectively. Adjusted EBITDA1 was $11.4 million versus $8.4 million for the prior-year period, or 11.1% and 11.7% of adjusted revenue, respectively.

Key Financial Indicators
For fiscal 2023, DLH has produced $15.0 million in operating cash. As of June 30, 2023, the Company had cash of $0.5 million and debt outstanding under its credit facilities of $195.8 million versus cash of $1.1 million and debt outstanding of $22.0 million as of September 30, 2022. The Company is on pace to reduce its total debt balance to between $185.0 million and $187.0 million by the end of this fiscal year.

At June 30, 2023, total backlog was approximately $817.8 million, including funded backlog of approximately $147.3 million and unfunded backlog of $670.5 million.

Conference Call and Webcast Details
DLH management will discuss third quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 10:00 AM Eastern Time tomorrow, August 3, 2023. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.   Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.     

A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 5343381.

About DLH
DLH (NASDAQ:DLHC) enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 3,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the risk that we will not realize the anticipated benefits of our acquisition of GRSi or any other acquisitions (including anticipated future financial performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations resulting from our recent acquisition; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our increased debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of GRSi or any future acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.

Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.


Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com


(Amounts in thousands except per share amounts)
 (unaudited) (unaudited)
 Three Months Ended Nine Months Ended
 June 30, June 30,
  2023  2022  2023  2022
Revenue$102,241 $66,440 $274,385 $327,940
Cost of Operations:       
Contract costs 80,919  49,668  216,779  271,184
General and administrative costs 9,935  7,535  27,670  22,178
Corporate development costs   250  1,735  250
Depreciation and amortization 4,280  1,873  11,281  5,740
Total operating costs 95,134  59,326  257,465  299,352
Income from operations 7,107  7,114  16,920  28,588
Interest expense 4,917  512  11,512  1,739
Income before provision for income taxes 2,190  6,602  5,408  26,849
Income tax expense 452  1,738  1,318  7,003
Net income$1,738 $4,864 $4,090 $19,846
Net income per share - basic$0.13 $0.38 $0.30 $1.55
Net income per share - diluted$0.12 $0.34 $0.28 $1.40
Weighted average common shares outstanding       
Basic 13,854  12,812  13,638  12,779
Diluted 14,539  14,235  14,421  14,205

(Amounts in thousands except par value of shares)
 June 30,
 September 30,
Current assets:   
Cash$530 $228
Accounts receivable 67,882  40,496
Other current assets 4,082  2,878
Total current assets 72,494  43,602
Equipment and improvements, net 1,690  1,704
Operating lease right-of-use assets 17,911  16,851
Goodwill 138,301  65,643
Intangible assets, net 128,891  40,884
Other long-term assets 88  328
Total assets$359,375 $169,012
Current liabilities:   
Operating lease liabilities - current$3,478 $2,235
Accrued payroll 17,545  9,444
Debt obligations - current, net of deferred financing costs 28,716  
Accounts payable and accrued liabilities 25,602  26,862
Total current liabilities 75,341  38,541
Long-term liabilities:   
Deferred taxes, net 1,203  1,534
Operating lease liabilities - long-term 16,485  16,461
Debt obligations - long-term, net of deferred financing costs 159,379  20,416
Other long-term liabilities 1,801  
Total long-term liabilities 178,868  38,411
Total liabilities 254,209  76,952
Shareholders' equity:   
Common stock, $0.001 par value; 40,000 shares authorized; 13,900 and 13,047 shares issued and outstanding at June 30, 2023 and September 30, 2022, respectively 14  13
Additional paid-in capital 100,072  91,057
Retained earnings 5,080  990
Total shareholders’ equity 105,166  92,060
Total liabilities and shareholders' equity$359,375 $169,012

(Amounts in thousands)
 Nine Months Ended
 June 30,
  2023   2022 
Operating activities   
Net income$4,090  $19,846 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:   
Depreciation and amortization 11,281   5,740 
Amortization of deferred financing costs charged to interest expense 1,540   497 
Stock-based compensation expense 2,020   1,952 
Deferred taxes, net    (1)
Changes in operating assets and liabilities:   
Accounts receivable (1,918)  (16,890)
Other current assets 130   (152)
Accrued payroll 274   4,032 
Deferred revenue    (22,273)
Accounts payable and accrued liabilities (4,221)  2,380 
Other long-term assets and liabilities 1,801   110 
Net cash provided by (used in) operating activities 14,997   (4,759)
Investing activities   
Business acquisition, net of cash acquired (180,711)   
Purchase of equipment and improvements (580)  (244)
Net cash used in investing activities (181,291)  (244)
Financing activities   
Proceeds from revolving line of credit 144,697    
Repayment of revolving line of credit (128,204)   
Proceeds from debt obligations 168,000   13,500 
Repayments of debt obligations (10,688)  (31,750)
Payments of deferred financing costs (7,666)   
Proceeds from issuance of common stock upon exercise of options and warrants 1,107   543 
Payment of tax obligations resulting from net exercise of stock options (650)  (281)
Net cash provided by (used in) financing activities 166,596   (17,988)
Net change in cash 302   (22,991)
Cash - beginning of period 228   24,051 
Cash - end of period$530  $1,060 
Supplemental disclosure of cash flow information   
Cash paid during the period for interest$10,006  $1,195 
Cash paid during the period for income taxes$4,055  $6,403 
Supplemental disclosure of non-cash activity   
Common stock surrendered for the exercise of stock options$238  $256 

Non-GAAP Financial Measures
The Company uses EBITDA and EBITDA Margin on Revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA Margin on Revenue is EBITDA for the measurement period divided by revenue for the same period.

The Company is presenting additional non-GAAP measures regarding its financial performance for the three and nine months ended June 30, 2023. The measures presented are Adjusted Revenue, Adjusted Operating Income, Adjusted EBITDA, and Adjusted EBITDA Margin on Adjusted Revenue. In calculating these measures, we have added the corporate development costs associated with completing the GRSi acquisition to our results for fiscal year 2023 and we have removed the contribution from the FEMA task orders from the results for fiscal year 2022. These resulting measures present the quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth below.

We have prepared these additional non-GAAP measures to eliminate the impact of items that we do not consider indicative of ongoing operating performance due to their inherent unusual or extraordinary nature. These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.

These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry. Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are not recognized measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance investors should (i) evaluate each adjustment in our reconciliation to the nearest GAAP financial measures and (ii) use the aforementioned non-GAAP measures in addition to, and not as an alternative to, revenue, operating income, net income or diluted EPS, as measures of operating results, each as defined under GAAP. We have defined these non-GAAP measures as follows:

“Adjusted Revenue” represents revenue less the contribution to revenue from the short-term FEMA task orders

“Adjusted Operating Income” represents operating income plus the corporate development costs associated with completing the GRSi acquisition incurred in fiscal 2023 less the contribution from the FEMA task orders, which occurred in fiscal 2022.

“Adjusted EBITDA” represents net income before income taxes, interest, depreciation and amortization and the corporate costs associated with completing the acquisition, less the contribution from FEMA task orders. “Adjusted EBITDA Margin on Adjusted Revenue” is calculated as Adjusted EBITDA divided by Adjusted Revenue.

Below is a reconciliation of Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue and Adjusted EBITDA Margin on Adjusted Revenue reported for the three and six months ended June 30, 2023 and 2022 compared to the most directly comparable financial measure calculated and presented in accordance with GAAP (in thousands except for per share amounts):

 Three Months Ended Nine Months Ended
 June 30, June 30,
  2023   2022  Change  2023   2022  Change
Adjusted Revenue           
Revenue$102,241  $66,440  $35,801  $274,385  $327,940  $(53,555)
Less: FEMA task orders to support Alaska (a)    (5,116)  5,116      125,773   (125,773)
Adjusted Revenue$102,241  $71,556  $30,685  $274,385  $202,167  $72,218 
Adjusted Operating Income           
Operating Income$7,107  $7,114  $(7) $16,920  $28,588  $(11,668)
Corporate development costs (b)          1,735      1,735 
Less: FEMA task orders to support Alaska (c)    608   (608)     12,479   (12,479)
Adjusted Operating Income$7,107  $6,506  $601  $18,655  $16,109  $2,546 
EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue & Adjusted EBITDA Margin on Adjusted Revenue           
Net Income$1,738  $4,864  $(3,126) $4,090  $19,846  $(15,756)
Depreciation and amortization 4,280   1,873   2,407   11,281   5,740   5,541 
Interest expense 4,917   512   4,405   11,512   1,739   9,773 
Income tax expense 452   1,738   (1,286)  1,319   7,003   (5,684)
EBITDA$11,387  $8,987  $2,400  $28,202  $34,328  $(6,126)
Corporate development costs (b)$  $  $  $1,735  $  $1,735 
Less: FEMA task order to support Alaska (c)    608   (608)     12,479   (12,479)
Adjusted EBITDA$11,387  $8,379  $3,008  $29,937  $21,849  $8,088 
Net income margin on Revenue 1.7%  7.3%    1.5%  6.1%  
EBITDA Margin on Revenue 11.1%  13.5%    10.3%  10.5%  
Adjusted EBITDA Margin on Adjusted Revenue 11.1%  11.7%    10.9%  10.8%  

(a): Represents revenue adjusted to exclude revenue from the short-term FEMA task orders during the three and nine months ended June 30, 2022.

(b): Represents corporate development costs we incurred to complete the GRSi transaction. These costs primarily include legal counsel, financial due diligence, customer market analysis and representation and warranty insurance premiums.

(c): Adjusted operating income represents the Company’s consolidated operating income, determined in accordance with GAAP, adjusted to add the corporate development costs associated with the GRSi acquisition for fiscal year 2023 and adjusted to exclude the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting contract costs of ($5.7) million from the revenue attributable to such task orders during the three months ended June 30, 2022 of ($5.1) million. Similarly, for the nine months ended June 30, 2022 operating income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs $112.1 million and general & administrative costs of $1.2 million.

1 Adjusted Operating Income,   EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are non-GAAP financial measures. See “Non-GAAP Financial Measures” below for additional detail.

Print Page
Email Alerts
RSS Feeds
Contact IR